Risk factors in aluminum toxicity in children with chronic renal failure.
D000138:Acidosis / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000535:Aluminum / Q000009:adverse effects* / Q000378:metabolism; D000536:Aluminum Hydroxide / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D001842:Bone and Bones / Q000378:metabolism; D002648:Child; D002951:Citrates / Q000378:metabolism / Q000627:therapeutic use; D019343:Citric Acid; D003676:Deferoxamine / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000172:deficiency; D010710:Phosphates / Q000097:blood / Q000378:metabolism; D010758:Phosphorus / Q000008:administration & dosage; D006435:Renal Dialysis; D012306:Risk; D014867:Water
D002951:Citrates; D010281:Parathyroid Hormone; D010710:Phosphates; D014867:Water; D010758:Phosphorus; D019343:Citric Acid; D000536:Aluminum Hydroxide; D000535:Aluminum; D003676:Deferoxamine